Cardinal Health (NYSE:CAH) Given New $232.00 Price Target at Argus

Cardinal Health (NYSE:CAH) had its price target boosted by Argus from $211.00 to $232.00 in a research note released on Friday,MarketScreener reports. Argus currently has a buy rating on the stock.

Other analysts also recently issued research reports about the company. Citigroup raised Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price target for the company from $190.00 to $244.00 in a research note on Friday, January 9th. Barclays began coverage on Cardinal Health in a research report on Monday, December 8th. They issued an “overweight” rating and a $243.00 target price on the stock. Evercore ISI boosted their target price on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research note on Friday, October 31st. Deutsche Bank Aktiengesellschaft raised their price target on shares of Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research note on Tuesday, November 18th. Finally, Jefferies Financial Group boosted their price objective on shares of Cardinal Health from $220.00 to $270.00 and gave the stock a “buy” rating in a research report on Thursday. Fourteen investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average target price of $221.07.

Cardinal Health Stock Performance

NYSE CAH traded up $1.40 during trading hours on Friday, reaching $208.29. 2,158,897 shares of the company’s stock were exchanged, compared to its average volume of 1,371,772. The company has a market capitalization of $49.49 billion, a price-to-earnings ratio of 31.42, a price-to-earnings-growth ratio of 1.40 and a beta of 0.65. The company’s 50-day moving average is $205.78 and its two-hundred day moving average is $176.18. Cardinal Health has a one year low of $120.72 and a one year high of $215.48.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The firm had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same quarter in the previous year, the firm posted $1.88 earnings per share. The business’s revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Research analysts predict that Cardinal Health will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd were given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend was Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Institutional Investors Weigh In On Cardinal Health

A number of large investors have recently added to or reduced their stakes in the business. Aventura Private Wealth LLC acquired a new position in shares of Cardinal Health in the fourth quarter valued at $25,000. SJS Investment Consulting Inc. boosted its holdings in shares of Cardinal Health by 1,363.6% during the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after buying an additional 150 shares during the period. Atlantic Edge Private Wealth Management LLC grew its stake in Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after buying an additional 75 shares during the last quarter. Barnes Dennig Private Wealth Management LLC raised its holdings in Cardinal Health by 38.7% in the 4th quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock valued at $39,000 after acquiring an additional 53 shares during the period. Finally, JPL Wealth Management LLC acquired a new stake in Cardinal Health during the third quarter worth approximately $31,000. Institutional investors own 87.17% of the company’s stock.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.